Kumar Sankhala, MD

Articles by Kumar Sankhala, MD

Dr. Sankhala on Challenges Facing the Treatment of Angiosarcoma

July 19th 2017

Kumar Sankhala, MD, medical director of Clinical Research, Sarcoma Oncology Center, discusses challenges facing the treatment of angiosarcoma.

Dr. Sankhala on the Significance of TRC105/Pazopanib in Angiosarcoma

ByKumar Sankhala, MD

April 10th 2017

Kumar Sankhala, MD, medical director of Clinical Research, Sarcoma Oncology Center, discusses the significance of the combination of the endoglin antibody TRC105 plus pazopanib (Votrient) in patients with angiosarcoma.

Dr. Sankhala on the TRC105/Pazopanib Combination in Angiosarcoma

ByKumar Sankhala, MD

November 12th 2016

Kumar Sankhala, MD, medical director of Clinical Research, Sarcoma Oncology Center, discusses results of a recent trial looking at the combination of endoglin antibody TRC105 and pazopanib in patients with advanced angiosarcoma.